Investigational Alzheimers drug slows rate of cognitive decline, study suggests
Researchers found that after two years of treatment on diranersen, participants demonstrated a 54% reduction in cognitive decline on the...
PJ view: Formulary approval alone will not get patients the medicines they need
Local formularies are slowing access to SGLT-2 inhibitors in parts of England, but an investigation by The Pharmaceutical Journal suggests...
Beyond the formulary: the hidden barriers to better heart failure care
The government has promised a relentless focus on delivery for its new cardiovascular–kidney metabolic plan. But clinicians warn progress will...
Lords committee calls for ‘careful evaluation’ of pharmacy vaccination role for children
The House of Lords Childhood Vaccination Committee has recommended that the supplementary provision of childhood vaccinations should be commissioned and...
15,000 patients per year could benefit from higher NICE thresholds, manufacturers say
An Association of the British Pharmaceutical Industry analysis of 20 medicines appraisals conducted after the cost-effectiveness threshold was raised, revealed...
Majority of people more confident managing minor ailments after pharmacy advice, survey finds
PAGB survey results also showed that after a conversation with a pharmacy team, one-third of respondents said their symptoms improved....